| Market Cap | ₹6.03Cr |
| ROE | -53.48% |
| P/E Ratio(TTM) | -5.83 |
| EPS(TTM) | -3.45 |
| P/B Ratio | 1.79 |
| Dividend Yield | 0.00% |
| Industry P/E | 39.94 |
| Book Value | 11.21 |
| Debt to Equity | 0.00 |
| Face Value | 10 |
| Parent Organisation | Brawn Biotech Limited |
| BSE Symbol | 530207 |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| Cohance Lifesciences | NA (0.00%) | 82.27 | ||
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.89 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 33.53 | ||
| Wockhardt | NA (0.00%) | -426.40 |